Form 4: Esperion Therapeutics Officer Joanne M. Foody Reports Stock Sale to Cover Tax Obligations
SEC Form 4 Filing
Joanne M. Foody, Chief Medical Officer of Esperion Therapeutics, sold 3,285 shares of common stock on June 18, 2024, to satisfy tax obligations related to vested restricted stock units.
Summary
- On June 18, 2024, Joanne M. Foody, the Chief Medical Officer of Esperion Therapeutics, Inc., sold 3,285 shares of the company's common stock.
- The sale was executed at a price of $2.867 per share.
- This transaction was reported on a Form 4 filing with the Securities and Exchange Commission.
- Following the transaction, Foody directly owns 273,779 shares of Esperion Therapeutics stock.
- The sale was conducted to cover tax obligations arising from the vesting of restricted stock units.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to a stock sale for tax purposes. It doesn't convey any strong positive or negative sentiment about the company's prospects.
Industry Context
This is a routine transaction related to executive compensation and tax obligations. It doesn't necessarily reflect a change in the executive's confidence in the company.
Stakeholder Impact
- The stock sale has a minimal impact on shareholders as it is a small transaction related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| June 28, 2021 | Date of execution of the Limited Power of Attorney. |
| 06/18/2024 | Date of stock sale transaction. |
| 06/20/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.